Price regulation and relative delays in generic drug adoption

Costa-Font Joan; McGuire Alistair; Varol Nebibe

首页> 外文期刊>Journal of health economics >Price regulation and relative delays in generic drug adoption

【24h】

Price regulation and relative delays in generic drug adoption

机译：价格管制和仿制药采用的相对延迟

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Increasing the adoption of generic drugs has the potential to improve static efficiency in a health system without harming pharmaceutical innovation. However, very little is known about the timing of generic adoption and diffusion. No prior study has empirically examined the differential launch times of generics across a comprehensive set of markets, or more specifically the delays in country specific adoption of generics relative to the first country of (generic) adoption. Drawing on data containing significant country and product variation across a lengthy time period (1999-2008), we use duration analysis to examine relative delays, across countries, in the adoption of generic drugs. Our results suggest that price regulation has a significant effect on reducing the time to launch of generics, with faster adoption in higher priced markets. The latter result is dependent on the degree of competition and the expected market size. (C) 2014 Elsevier B.V. All rights reserved.

机译：越来越多地采用仿制药有可能在不损害药物创新的情况下提高卫生系统的静态效率。但是，对于通用采用和传播的时间知之甚少。之前的研究都没有从经验上考察过在整个市场中使用非专利药的时间差异，或更具体地讲，相对于（非专利）采用的第一个国家，特定国家/地区采用非专利药的时间有所延迟。利用包含在较长时间段（1999-2008年）中国家和产品的重大差异的数据，我们使用持续时间分析来研究各国在采用仿制药方面的相对延误。我们的结果表明，价格管制对缩短仿制药上市时间具有重要影响，并且在较高价格的市场中采用得更快。后者的结果取决于竞争程度和预期的市场规模。（C）2014 Elsevier B.V.保留所有权利。

著录项

来源
《Journal of health economics》 |2014年第12期|1-9|共9页
作者
Costa-Font Joan; McGuire Alistair; Varol Nebibe;
展开▼
作者单位

Univ London London Sch Econ & Polit Sci, Dept Social Policy LSE Hlth, London WC2A 2AE, England;

Univ London London Sch Econ & Polit Sci, Dept Social Policy LSE Hlth, London WC2A 2AE, England;

Univ London London Sch Econ & Polit Sci, Dept Social Policy LSE Hlth, London WC2A 2AE, England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Generic competition; Regulation; Adoption; Duration analysis;

机译：通用竞争;监管;采用;持续时间分析;

相似文献

外文文献
中文文献
专利

1. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending. [J] . Kesselheim AS, Fischer MA, Avorn J Health affairs . 2006,第6期

机译：知识产权的扩展和仿制药的延迟采用：对医疗支出的影响。
2. Debate over Delays to EU Market for Generics ContinuesAn expert panel convened at the Drug Information Association's EuroMeeting to consider complaints that access to market in Europe for generic drugs is delayed. Faraz Kermani reports. [J] . Faraz Kermani The regulatory affairs journal: Pharma . 2009,第5期

机译：欧盟仿制药市场延期辩论仍在继续药物信息协会（EuroMeeting）召集的一个专家小组审议了有关仿制药进入欧洲市场的延误的投诉。 Faraz Kermani报告。
3. Generic drugs, a need to the public: USA and India – Government plans to reduce the price of abbreviated new drug application and list of generic drugs approved in year 2018 [J] . Russell Martin, Kavita Bahmani Journal of generic medicines . 2019,第3期

机译：通用药物，需要公众：美国和印度 - 政府计划减少缩写新药物申请和2018年批准的普通药物清单
4. Study of Drug Price Regulation in China: An International Comparative Perspective [C] . Liang Xue-feng, Qiao Tian-wen, Zheng De-quan, . 2006

机译：中国药品价格管制研究：国际比较视角
5. Generic Drug Policy in the U.S. – Impact on Drug Prices and Shortages [D] . Gupta, Ravi 2017

机译：美国的仿制药政策 - 对药品价格和短缺的影响
6. BC government reveals plans to lower generic drug prices to 20 of brand-name price by April 2014 [O] . Kathie Lynas 2013

机译：卑诗省政府透露计划到2014年4月将仿制药价格降低至品牌价格的20％
7. Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008 [O] . Costa-i-Font Joan, Varol Nebibe, McGuire Alistair 2011

机译：药品价格监管会影响仿制药竞争的采用吗？：经合组织的证据，1999-2008年

Price regulation and relative delays in generic drug adoption

摘要

著录项

相似文献

相关主题

期刊订阅